2 November: Slovenia presents proposed new national dementia strategy until 2030
After a meeting of the Slovenian Council for Dementia Management, on 2 November, at the Office of the President of the Republic of Slovenia, the Slovenian Ministry of Health launched a public debate regarding the proposed National Dementia Strategy until 2030. The Strategy was prepared by an interdisciplinary working group, whose members include Štefanija L. Zlobec, president of Alzheimer Slovenia.
Read more »
|
30 November: Roche discontinues clinical trials of gantenerumab
Unfortunately, Roche had to present disappointing results at the Clinical Trials in Alzheimer’s Disease (CTAD) conference in San Francisco. Its GRADUATE I and II clinical trials of gantenerumab failed to meet their primary and secondary endpoints and as a consequence of these negative results, the company announced that it would be discontinuing most of its global clinical trials of gantenerumab.
Read more »
|
|
|
|
|